Company news

Medicure Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Medicure announces results of 2022 agm

June 20, 2022

Medicure reports financial results for quarter ended March 31, 2022 and appointment of Haaris Uddin as Chief Financial Officer

May 30, 2022

Medicure reports financial results for quarter and Year Ended December 31, 2021

April 27, 2022

Medicure to report financial results for year ended December 31, 2021 on April 28th at 7: 30 AM cst

April 26, 2022

Medicure announces resignation of Chief Financial Officer and succession plan

March 23, 2022

Medicure's Subsidiary - Marley Drug to Partner with RxSpark, the Next Generation in Pharmacy Discount Programs, to be its Sole Mail-Order Pharmacy

February 22, 2022

Medicure Launches E-Commerce Pharmacy Platform - www.marleydrug.com Through its Subsidiary Marley Drug Pharmacy

February 9, 2022

Medicure Reports Financial Results for Quarter Ended September 30, 2021

November 22, 2021

Medicure Plans To Launch Innovative E-Commerce Pharmacy Platform Offering Hundreds of Medications Directly To Millions of Americans

November 22, 2021

Medicure Announces that the Shortened AGGRASTAT® Versus INTEGRILIN® in Percutaneous Coronary Intervention (SAVI-PCI) Study has Met its Primary Endpoint

November 4, 2021

Medicure Announces Grant of Stock Options

July 30, 2021

Medicure Announces Appointment of David Gurvey as Chief Financial Officer

June 24, 2021

Medicure Reports Financial Results for Quarter Ended March 31, 2021

May 10, 2021

Medicure 2020 Annual and Q1 2021 Results and Conference Call Date

May 5, 2021

Medicure Announces Resignation of Chief Financial Officer and Succession Plan

April 28, 2021

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2020

April 20, 2021

Medicure to Participate in Renmark's Virtual Non-Deal Roadshow Series on Tuesday, March 30, 2021

March 29, 2021

Medicure to Participate in Renmark's Virtual Non-Deal Roadshow Series on Tuesday, March 9, 2021

March 8, 2021

Medicure to Participate in Renmark's Virtual Non-Deal Roadshow Series on Tuesday, February 23, 2021

February 22, 2021

Medicure To Participate In Renmark's Virtual Non-Deal Roadshow Series on Monday, February 8, 2021

February 4, 2021

Medicure Announces Early Completion of Enrollment for iSPASM, a Phase 1/2a Exploratory Clinical Trial of AGGRASTAT® (tirofiban hydrochloride) Injection vs. Placebo for Induced Suppression of Platelets Activity in Aneurysmal Subarachnoid Hemorrhage Management

January 27, 2021

Medicure Announces Pivotal Phase 3 Trial IND Filing with FDA for Treatment of Seizures Associated with Pyridox(am)ine 5'-phosphate oxidase (PNPO) Deficiency

January 7, 2021

Medicure Enters the US Online Pharmacy World with Acquisition of Marley Drug

December 17, 2020

Medicure Retains Investor Relations Firm Renmark Financial Communications Inc.

December 2, 2020

Medicure Announces Settlement of Patent Infringement Action

November 18, 2020

Medicure Reports Financial Results for Quarter Ended September 30, 2020

November 11, 2020

Medicure Q3 2020 Results and Conference Call Dates

November 5, 2020

Medicure announces an agreement with Reliance Life Sciences for the marketing rights of a cardiovascular biosimilar

October 5, 2020

Medicure Announces AGGRASTAT® Shows Promise in Treating Thrombotic Complications Due to COVID-19 in Early Clinical Reports

August 24, 2020

Medicure Announces Termination of ReDSTM Pro Marketing and Distribution Agreement

August 20, 2020

Medicure Reports Financial Results for Quarter Ended June 30, 2020

August 11, 2020

Medicure Q2 2020 Results and Conference Call Dates

August 5, 2020

Medicure Announces Normal Course Issuer Bid

June 29, 2020

Medicure Announces Positive Results for AGGRASTAT® in the FABOLUS-FASTER Trial and Publication in the Journal - Circulation

June 29, 2020

Medicure Announces a Direct to Patient Online Pharmacy Program for Distribution of ZYPITAMAG(TM) (Pitavastatin) Tablets

June 25, 2020

C-Suite At The Open: Albert Friessen, Chair & CEO from Medicure Inc. tells his Company story. Filmed May 2020.

June 18, 2020

Medicure Announces Top Line Data from FABOLUS-FASTER Trial With AGGRASTAT® will be Presented at the PCR e-Course, Late Breaking Trial Sessions, June 27, 2020

June 15, 2020

Medicure Reports Financial Results for Quarter Ended March 31, 2020

May 12, 2020

Medicure Q1 2020 results and conference call dates

May 6, 2020

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2019

April 15, 2020

Medicure To Announce Fiscal Year End 2019 Financial Results on April 15, 2020

April 13, 2020

Early Warning News Release - Dr. Albert D. Friesen Holdings in Medicure Inc.

December 31, 2019

Medicure Announces Preliminary Results of Substantial Issuer Bid

December 20, 2019

Medicure Announces the Completion of Shortened AGGRASTAT® Versus Integrilin® in Percutaneous Coronary Intervention (SAVI-PCI) Study

December 17, 2019

Medicure Announces Completion of Enrollment for FABOLUS-FASTER, Phase 4 Clinical Trial of Aggrastat (Tirofiban Hydrochloride) Injection VS Kengreal (Cangrelor) in Patients Undergoing Percutaneous Coronary Intervention (PCI)

December 12, 2019

Medicure Announces Settlement of Holdback Dispute from Apicore Sale

December 5, 2019

Medicure Files Patent Infringement Action

December 5, 2019

Medicure Reports Financial Results for Quarter Ended September 30, 2019

November 26, 2019

Medicure Q3 2019 Results and Conference Call Dates

November 19, 2019

Medicure Announces Commencement of Substantial Issuer Bid

November 13, 2019

← Newer news releases · Older news releases →

Calls

The 5 newest of 24 calls. Every call is listed under its year.

Decks

The 5 newest of 14 decks. Every deck is listed under its year.